CAIAZZO, GIUSEPPINA
 Distribuzione geografica
Continente #
AS - Asia 1.845
NA - Nord America 1.660
EU - Europa 1.246
SA - Sud America 252
Continente sconosciuto - Info sul continente non disponibili 110
AF - Africa 57
OC - Oceania 2
Totale 5.172
Nazione #
US - Stati Uniti d'America 1.584
SG - Singapore 801
RU - Federazione Russa 582
CN - Cina 380
VN - Vietnam 350
IT - Italia 248
BR - Brasile 203
HK - Hong Kong 113
DE - Germania 82
FR - Francia 64
FI - Finlandia 55
GB - Regno Unito 50
IN - India 46
CA - Canada 43
IE - Irlanda 41
NL - Olanda 37
JP - Giappone 26
KR - Corea 26
CI - Costa d'Avorio 25
UA - Ucraina 22
BD - Bangladesh 21
PL - Polonia 19
AR - Argentina 18
MX - Messico 17
TH - Thailandia 11
TR - Turchia 11
ZA - Sudafrica 11
PH - Filippine 10
EC - Ecuador 8
ES - Italia 8
IQ - Iraq 8
SE - Svezia 8
VE - Venezuela 8
PK - Pakistan 6
BE - Belgio 5
JM - Giamaica 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
RO - Romania 4
SN - Senegal 4
TW - Taiwan 4
CL - Cile 3
CO - Colombia 3
DK - Danimarca 3
ID - Indonesia 3
LT - Lituania 3
TN - Tunisia 3
UZ - Uzbekistan 3
AT - Austria 2
AZ - Azerbaigian 2
DZ - Algeria 2
EG - Egitto 2
GA - Gabon 2
IR - Iran 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
MA - Marocco 2
NP - Nepal 2
PR - Porto Rico 2
RS - Serbia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
AI - Anguilla 1
AM - Armenia 1
AS - Samoa Americane 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CM - Camerun 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GP - Guadalupe 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
LB - Libano 1
LU - Lussemburgo 1
ME - Montenegro 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 5.063
Città #
Singapore 403
San Jose 279
Ashburn 151
Moscow 136
Chandler 134
Beijing 114
Hong Kong 110
Ho Chi Minh City 89
Hanoi 85
Hefei 75
Santa Clara 73
Council Bluffs 47
Napoli 47
Naples 46
Los Angeles 43
Lauterbourg 40
The Dalles 38
Millbury 31
Amsterdam 28
Helsinki 26
Des Moines 24
Buffalo 22
Boston 21
Frankfurt am Main 20
Tokyo 20
New York 18
Dallas 17
Nanjing 17
Princeton 17
Phoenix 16
Rome 16
Orem 15
Redondo Beach 15
Turku 15
Da Nang 14
Dong Ket 14
Lawrence 13
Munich 13
Seoul 13
São Paulo 13
Warsaw 13
Chicago 12
Haiphong 12
Ottawa 12
Chennai 11
Jacksonville 11
Seattle 10
Boardman 9
Brooklyn 9
Denver 9
Dublin 9
Falkenstein 9
Rio de Janeiro 9
Arezzo 8
Houston 8
Kochi 8
London 8
Mexico City 8
Milan 8
Montreal 8
Toronto 8
Atlanta 6
Guarulhos 6
Hải Dương 6
Nanchang 6
Shenyang 6
Trecase 6
Wilmington 6
Woodbridge 6
Abidjan 5
Catania 5
Curitiba 5
Düsseldorf 5
Guangzhou 5
Jiaxing 5
Poplar 5
Shenzhen 5
Tân Tiến 5
Baghdad 4
Biên Hòa 4
Dakar 4
Guayaquil 4
Lappeenranta 4
Miami 4
Norwalk 4
Nuremberg 4
Pune 4
Quận Bình Thạnh 4
Raleigh 4
San Francisco 4
Shanghai 4
Stockholm 4
Thái Nguyên 4
Washington 4
Asunción 3
Brasília 3
Brussels 3
Bucharest 3
Can Tho 3
Caxias do Sul 3
Totale 2.702
Nome #
Loss of p53 activates thyroid hormone via type 2 deiodinase and enhances DNA damage 191
Anti-TNF-α therapy modulates mTORC1 signalling in hidradenitis suppurativa 182
Exploring Anti-Fungal, Anti-Microbial and Anti-Inflammatory Properties of a Topical Non-Steroidal Barrier Cream in Face and Chest Seborrheic Dermatitis 177
Antiflammatory activity and potential dermatological applications of characterized humic acids from a lignite and a green compost 168
IL-26 in allergic contact dermatitis: resource in a state of readiness 159
Possible role of BMP-4 in the hyper-pigmentation of psoriatic plaques after anti-TNF-α treatment 157
Use of Natural Agents and Agrifood Wastes for the Treatment of Skin Photoaging 151
A new T helper 17 cytokine in hidradenitis suppurativa: antimicrobial and proinflammatory role of interleukin-26 148
Immunologic skin signatures in SARS-CoV-2-negative patients with chilblain-like lesions. 143
Azeloglycine and nicotinamide down-regulate pro-inflammatory mediators in vitro 142
Mammalian target of rapamycin is increased in hidradenitis suppurativa and acne being related to insulin resistance 140
Eczematous drug eruption in patients with psoriasis under anti‐interleukin‐17A: does interleukin‐22 play a key role? 137
Psoriasis, cardiovascular events, and biologics: Lights and shadows 134
Irisin, a novel metabolic biomarker in hidradenitis suppurativa: correlation with clinical responsivity to anti-TNF-α therapy 131
IL-36γ Is Involved in Psoriasis and Allergic Contact Dermatitis 127
Safety concerns with current treatments for psoriasis in the elderly 127
Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders 126
Beneficial effects of Rocchetta® oligomineral water in HaCaT keratinocytes after ultraviolet-B irradiation 125
Chronic hand Eczema: Is IL-36á helpful in diagnosis and classification? 124
The Use of JAK/STAT Inhibitors in Chronic Inflammatory Disorders 124
Effectiveness of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis Located in Difficult-to-Treat Areas 122
Desmosomes in heart and skin: friends or foes? 119
Very low-calorie ketogenic diet (VLCKD) in the management of hidradenitis suppurativa (Acne Inversa): an effective and safe tool for improvement of the clinical severity of disease. Results of a pilot study 119
Increased expression of interleukin-23A in lesional skin of patients with atopic dermatitis with psoriasiform reaction during dupilumab treatment 118
Mechanistic target of rapamycin complex 1 is involved in psoriasis and regulated by anti-TNF-α treatment 117
The increase of mTOR expression is consistent with FoxO1 decrease at gene level in acne but not in psoriasis 116
IL-36 cytokines are increased in acne and hidradenitis suppurativa 114
Psoriatic arthritis onset in psoriatic patients receiving UV phototherapy in Italy 111
Mesenchymal stem cells participate to inflammatory skin process of atopic dermatitis 106
Response to: 'Interleukin-36 in hidradenitis suppurativa: Evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop' 106
The anti-drug antibodies detection: a valuable tool for clinical response loss in psoriatic patients? 105
Reply to "Psoriasis exacerbation after Covid-19 vaccination: report of 14 cases from a single center" by Sotiriou E et al 98
Author reply to: Comment on: 'Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?' 96
Polymorphic light eruption and IL-1 family members: any difference with allergic contact dermatitis? 94
Mammalian target of rapamycin, insulin resistance and hidradenitis suppurativa: A possible metabolic loop 92
Paraoxonases and psoriasis: negative imbalance of anti--oxidant endogenous mechanisms 92
Anti IL-17 therapy rapidly decreases osteoclast activity in psoriatic patients: a novel quality in addition to its efficacy and safety 91
Mechanistic target of rapamycin (mTOR) expression is increased in acne patients' skin. 90
Very low-calorie ketogenic diet (VLCKD): a therapeutic nutritional tool for acne? 86
The effects of etanercept on replication, proliferation, survival, and apoptosis markers in moderate to severe psoriasis. 85
Small fragments sodium sulfated hyaluronate, more than hyaluronic acid, reduces LPS-induced cytokine/chemokine levels in HaCaT cells 82
The effect of tildrakizumab on adipokines production in patients affected by psoriasis and obesity: preliminary results from a single center real-life study 64
Phenotype-endotype relationship in elderly atopic dermatitis and effects of dupilumab therapy: prospective study 36
Totale 5.172
Categoria #
all - tutte 17.270
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.270


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022200 0 0 6 1 6 17 1 4 25 17 50 73
2022/2023317 32 35 9 23 37 29 2 27 57 24 27 15
2023/2024282 12 36 17 35 20 29 4 45 9 17 39 19
2024/20251.337 59 62 22 21 46 82 132 108 85 149 479 92
2025/20262.444 228 200 263 233 419 99 262 139 318 170 60 53
2026/2027238 70 85 83 0 0 0 0 0 0 0 0 0
Totale 5.172